GVCCX | VMVAX | GVCCX / VMVAX | |
Total Expense Ratio | 2.20 | 0.07 | 3,143% |
Annual Report Gross Expense Ratio | 2.20 | 0.07 | 3,143% |
Fund Existence | 25 years | 14 years | - |
Gain YTD | 15.749 | 5.198 | 303% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 224M | 31B | 1% |
Annual Yield % from dividends | 0.00 | 2.22 | - |
Returns for 1 year | 11.82 | 7.67 | 154% |
Returns for 3 years | -8.02 | 17.51 | -46% |
Returns for 5 years | -17.82 | 65.15 | -27% |
Returns for 10 years | -49.22 | 87.87 | -56% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PORTX | 61.31 | 0.16 | +0.26% |
Trillium ESG Global Equity Investor | |||
IEOSX | 16.33 | -0.06 | -0.37% |
Voya Large Cap Growth Port S | |||
LIFLX | 15.38 | -0.07 | -0.45% |
Lord Abbett Focused Large Cap Value I | |||
ERASX | 41.31 | -0.28 | -0.67% |
Eaton Vance Atlanta Capital SMID-Cap R6 | |||
HNVIX | 35.27 | -0.31 | -0.87% |
Heartland Value Plus Institutional |